Company / Operating Income per Share
Gossamer Bio, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.75
FY2025
5-year range
-$2.89 / -$0.27
FY2021-FY2025
Trend
-183.4%
vs FY2024
Sector context
#84 of 201
Health Care
What the data says
At $-0.75, Gossamer Bio, Inc.'s operating income per share ranks #84 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 9 years, ranging from $-22.90 in FY2018 to $-0.27 in FY2024.
Based on SEC 10-K filings.
-0.75 in FY2025.
Improved from $-1.20 to $-0.75 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 201 in Health CareTop 42% of 201This company -$0.75 Sector average -$28.56
▼
+97.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 183.4% year-over-year.
- Ranks #84 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.75 | -183.4% |
| FY2024 | -$0.27 | +77.9% |
| FY2023 | -$1.20 | +53.4% |
| FY2022 | -$2.58 | +10.5% |
| FY2021 | -$2.89 | +15.4% |
| FY2020 | -$3.41 | -0.4% |
| FY2019 | -$3.40 | +85.2% |
| FY2018 | -$22.90 | -3053.9% |
| FY2017 | -$0.73 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026